Credit Agricole’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Credit Agricole’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,200	Closed	-$9K	–	538
2020 Q1	$9K	Buy	+1,200	New	+$15K	﹤0.01%	418
2017 Q4	–	Sell	-37,500	Closed	-$2.03M	–	1249
2017 Q3	$2.03M	Sell	37,500 -1,900	-5%	-$112K	0.01%	893
2017 Q2	$2.21M	Buy	39,400 +34,400	+688%	+$1.38M	0.01%	900
2017 Q1	$196K	Buy	+5,000	New	+$159K	﹤0.01%	1543
2016 Q4	–	Sell	-2,500	Closed	-$57K	–	1594
2016 Q3	$57K	Hold	2,500	–	–	﹤0.01%	1545
2016 Q2	$59K	Hold	2,500	–	–	﹤0.01%	1433
2016 Q1	$51K	Hold	2,500	–	–	﹤0.01%	1215
2015 Q4	$129K	Hold	2,500	–	–	﹤0.01%	1317
2015 Q3	$107K	Hold	2,500	–	–	﹤0.01%	1350
2015 Q2	$114K	Sell	2,500 -2,500	-50%	-$101K	﹤0.01%	1321
2015 Q1	$190K	Hold	5,000	–	–	﹤0.01%	1343
2014 Q4	$138K	Buy	+5,000	New	+$139K	﹤0.01%	1438

Other funds holding PTLA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Credit Agricole's PTLA Position: Q2 2020 in Review

Credit Agricole sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 1,200 shares — an estimated $9K sold.

Credit Agricole first reported a position in PTLA in Q4 2014 and held it in 12 quarters. The position peaked at $2.21M in Q2 2017. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

Credit Agricole reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
Credit Agricole sold 1,200 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $9K.
Credit Agricole first reported a position in Portola Pharmaceuticals, Inc. in Q4 2014 and held it in 12 quarters.
Credit Agricole's Portola Pharmaceuticals, Inc. position peaked at $2.21M in Q2 2017.
162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Credit Agricole's 13F filing for Q2 2020, filed 13 Aug 2020.